The Pathologist

Reporting on all aspects of pathology and diagnostics; from the latest innovations, to the controversies, and the inspirational people at the heart of it.

Read the full article here

Source: The Pathologist

Categories: Hem/Oncs, Latest Headlines

Tags: ASH20, HemeTakeOver

Tweets with this article

Sanam Loghavi, MD

What better way to end the week than w/ the @pathologistmag #HemeTakeOver in honor of #ASH20 case discussion are now live! https://t.co/bcmj2cerXm Join us in the next few days as we discuss 8 cases,representing either diagnostic or therapeutic challenges @KMirza @MichaelPathMag

Niaz Zia (@niaz_zia) • Instagram photos and videos

77K Followers, 1,294 Following, 229 Posts – See Instagram photos and videos from Niaz Zia (@niaz_zia)

Sanam Loghavi, MD April 21, 2024

Venetoclax and Low-Dose Cytarabine for Measurable Residual Disease or Oligoblastic Relapse in Patients With AML

Read it now on PracticeUpdate.com

Sanam Loghavi, MD March 29, 2024

Venetoclax and Low-Dose Cytarabine for Measurable Residual Disease or Oligoblastic Relapse in Patients With AML

Read it now on PracticeUpdate.com

Sanam Loghavi, MD March 28, 2024

Validate User

We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will…

Sanam Loghavi, MD March 21, 2024

5TH EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES

This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambig…

Sanam Loghavi, MD March 10, 2024

SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma? – PubMed

Large or blastoid B-cell neoplasms that are SOX11+ are a diagnostic dilemma and raise a differential diagnosis of cyclin D1-negative blastoid/pleomorphic mantle cell lymphoma (MCL)…

Sanam Loghavi, MD March 2, 2024

Related Articles